Clinical Trial Update: Meloxicam in Mohs Micrographic Surgery [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating meloxicam for postoperative pain management in Mohs micrographic surgery for skin cancer patients is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skin Cancer

Drugs mentioned

• MELOXICAM (MELOXICAM)

Snippet

Sponsor: University of Oklahoma | Conditions: Postoperative Pain, Acute, Skin Cancer | Phase 4 | Status: RECRUITING